ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter (PREFACE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00736294
Recruitment Status : Terminated (Difficulty to include patients)
First Posted : August 15, 2008
Last Update Posted : July 28, 2015
Sponsor:
Collaborators:
Sanofi
Ministry of Health, France
LivaNova
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Saint Etienne

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 2015
  Actual Study Completion Date : March 2015
Publications: